top of page

REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL

Product details

Registration number: SIN16471P

Classification: Prescription Only

Active ingredients: Luspatercept

Strength: 75.0 MG/vial

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: SUBCUTANEOUS

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

ATC code: B03XA06

HSA approval date: 6 April 2022

Manufacturer(s): Patheon Italia S.p.A.

Manufacturing country/countries: ITALY

What are the HSA registration number and classification for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16471P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Luspatercept

Strength: 75.0 MG/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: SUBCUTANEOUS

Source for this answer

Who is the recorded registrant for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Patheon Italia S.p.A.

Manufacturing country/countries: ITALY

Source for this answer

Where can I look up REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16471P or the exact product name REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this REBLOZYL POWDER FOR SOLUTION FOR INJECTION 75 MG/VIAL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16471P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page